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A three-year-old male child presented with erythematous maculopapular nonpruritic generalized rash, poor feeding, vomiting,
and cramping generalized abdominal pain. He was previously healthy and there was no family history of immunologic or other
diseases. On examination he was afebrile, hemodynamically stable, with painful palpation of the right upper quadrant and
positiveMurphy’s sign. Laboratory tests revealed elevated inflammatorymarkers, elevated aminotransferase activity, and features of
cholestasis. Abdominal ultrasound showed gallbladder wall thickening of 8mmwith a positive sonographicMurphy’s sign, without
gallstones or pericholecystic fluid. Acute Alithiasic Cholecystitis (AAC) was diagnosed. Tests for underlying infectious causes were
negative except positive blood specimen for HumanHerpes Virus Type-6 (HHV-6) by polymerase chain reaction.With supportive
therapy the child became progressively less symptomatic with gradual improvement. The child was discharged on the sixth day,
asymptomatic and with improved analytic values. Two months later he had IgM negative and IgG positive antibodies (1/160) for
HHV-6, which confirmed the diagnosis of previous infection. In a six-month follow-up period he remains asymptomatic. To the
best of our knowledge, this represents the first case of AAC associated with HHV-6 infection.
1. Introduction
Acute Alithiasic Cholecystitis (AAC) is defined as an acute
necroinflammatory disease of the gallbladder in the absence
of cholelithiasis [1, 2]. It accounts for approximately 2–15% of
all cases of acute cholecystitis [3].
The pathogenesis of AAC is multifactorial and likely
results from bile stasis, ischemia, or both [1–3]. Bile stasis can
be caused by fasting, obstruction, postsurgical or procedural
irritation, or ileus, which can lead to bile inspissation that
is directly toxic to the gallbladder epithelium [3]. Ischemia
may occur from systemic inflammation and could have
deleterious effects directly to all layers of the gallbladder
wall [3]. Various conditions predispose to its occurrence:
trauma, recent surgery, shock, burns, total parenteral nutri-
tion, chronic diseases, and viral (hepatotropic virus) or
bacterial (mostly gram-negative or anaerobic) infections
[1–3].
The diagnosis of AAC is difficult and relies on combina-
tion of clinical history, physical examination, laboratory tests,
and radiologic image [1–6].
Treatment depends on the time of diagnosis. In early
stages, conservative treatment is sufficient [2–7]. Surgical
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Table 1: Laboratory tests at admission.
Parameters at admission Values Reference range
Hematologic values
Hemoglobin 12.1 g/dL 11.5–13.5
Hematocrit 34.3% 34.0–40.0
Mean corpuscular volume 76.2 fL 75.0–87.0
Mean corpuscular hemoglobin 35.3 g/dL 31.0–37.0
Leukocytes 10.3 × 103/𝜇L 5.0–14.5
Neutrophils 6.9 × 103/𝜇L 1.0–8.5
Lymphocytes 1.8 × 103/𝜇L 1.5–8.0
Platelets 341 × 103/𝜇L 200–450
Blood coagulation tests
Activated partial thromboplastin Time 34.4 seconds 25.0–35.0
Prothrombin time 14.0 seconds 8.0–14.0
International normalized ratio 1.0 0.1–1.2
Biochemistry
Urea 24mg/dL 15–39
Creatinine 0.3mg/dL 0.31–0.42
Sodium 137mmol/L 136–145
Potassium 4.0mmol/L 3.5–5.1
Chlorides 103mmol/L 98–107
Amylase 26U/L 5–65
Lipase 64U/L 73–393
Total bilirubin 0.62mg/dL 0.1–1.0
Direct bilirubin ↑ 0.34mg/dL 0.0–0.2
ALT ↑ 717U/L 12–78
AST ↑ 727U/L <50
GGTP ↑ 364U/L 4–22
ALP ↑ 536U/L <362
CRP ↑ 55.6mg/L <3.0
Polymerase chain reaction
HHV-6 Positive
2 months later Values Reference range
HHV-6 Atc IgM Negative <1/20
HHV-6 Atc IgG Positive 1/160 <1/80
ALP: alkaline phosphatase; ALT: alanine aminotransferase; AST: aspartate aminotransferase; CRP: C-reactive protein; GGTP: g-glutamyl transferase.
procedures like cholecystectomy should be reserved for
patients with complications [2–7].
Complications of AAC may occur in about 40% of the
cases (gangrene, perforation, and empyema) [1–3]. Mortality
depends on the underlying medical condition, ranging from
90% in critically ill patients up to 10% in the outpatient [1–3].
2. Case Description
A three-year-old male child presented with a two-day history
of erythematousmaculopapular nonpruritic generalized rash
and a one-day history of malar erythema, poor feeding,
vomiting, and abdominal pain. He was previously healthy
and there was no family history of immunologic or other
diseases. The child did not have a previous or recent history
of exanthem subitum. There was not a similar exposure
in his family members. On examination he was afebrile,
hemodynamically stable, with painful palpation of the right
upper quadrant and positive Murphy’s sign. He had no
lymphadenopathy or hepatosplenomegaly. The rest of the
examination was unremarkable. Laboratory tests revealed
elevated inflammatory markers (C-reactive protein (CRP)
55.6mg/L, reference range (RR) < 3.0), elevated amino-
transferase activity (alanine aminotransferase (ALT) 727U/L,
RR 12–78, aspartate aminotransferase (AST) 717U/L, RR
< 50), and features of cholestasis (g-glutamyl transferase
(GGTP) 364U/L, RR 4–22, alkaline phosphatase (ALP)
536U/L, RR < 362, and direct bilirubin 0.34mg/dL,RR 0.0–
0.2). Blood coagulation tests and total bilirubin were normal
(Table 1). Abdominal ultrasound showed gallbladder wall
thickening of 8mm with a positive sonographic Murphy’s
sign, without gallstones or pericholecystic fluid. An AACwas
diagnosed.Hospitalizationwas decided for intravenous fluids
and clinical and analytic monitorization. Tests for underlying
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causes of AAC, including Human Immunodeficiency Virus
(HIV), Hepatitis A Virus (HAV), toxoplasmosis, Epstein-
Barr Virus (EBV), Cytomegalovirus (CMV), Parvovirus B19,
andMycoplasma pneumonia, were negative. Blood specimen
deoxyribonucleic acid (DNA) for Human Herpes Virus
Type-6 (HHV-6) by polymerase chain reaction was positive.
Serologic tests for hepatitis B and hepatitis C were not done
because maternal third-trimester serology was negative.
The child became progressively less symptomatic with
gradual improvement. Forty-eight hours later ultrasono-
graphic examination showed decreased wall thickening. The
child was discharged on the sixth day, asymptomatic andwith
improved analytic values: CRP 5.31mg/L, ALT 202U/L, AST
51U/L, GGTP 389U/L, ALP 484U/L, and direct bilirubin <
0.10mg/dL.There was no need for treatment with antibiotics,
antiviral, or parenteral nutrition. One month later he had
normal values for inflammatory markers and normal amino-
transferase activity and no cholestasis. Two months later he
had IgM negative and IgG positive antibodies (1/160) for
HHV-6, which confirmed the diagnosis of previous infection.
In a six-month follow-up period he remains asymptomatic.
3. Discussion
To the best of our knowledge, this represents the first case of
AAC associated with HHV-6 infection.
HHV-6 is ubiquitous beta herpes virus [8]. It exhibits
a wide cell tropism in vivo and induces a lifelong latent
infection in humans. The diagnosis of HHV-6 infection is
performed by both serologic and direct methods [8, 9]. The
most prominent technique is the quantification of viral DNA
in blood, other body fluids, and tissues by means of real-time
polymerase chain reaction (PCR) [8, 9]. Many active HHV-
6 infections are asymptomatic and correspond to primary
infections, reactivations, or exogenous reinfections.However,
HHV-6 may be the cause of serious diseases, particularly in
immunocompromised. An emblematic example of HHV-6
pathogenicity is exanthema subitum (also known as roseola
infantum or sixth disease), a generally benign febrile exan-
them of infancy, associated with primary infection. Treat-
ment is supportive and recovery is usually complete with no
significant sequelae [9].The antiviral compounds ganciclovir,
foscarnet, and cidofovir are effective against active HHV-6
infections, but the indications for treatment, as well as the
conditions of drug administration, are not formally approved
to date [8].
Gallbladder disease is rare in the pediatric population [1–
3, 10]. AAC accounts for 30–50% of pediatric cholecystitis
cases [10]. In most cases, AAC in children occurs during the
course of infectious diseases. AAC caused by viral infection is
extremely rare in the pediatric population. Ultrasonography
is the main diagnostic radiologic exam of acute cholecystitis
(efficiency is approximately 90%) [11, 12]. Criteria such as
gallbladder wall thickening over 3mm, gallbladder disten-
tion, localized tenderness, pericholecystic fluid, and sludge
have been used for the diagnosis. A combination of at
least two of the above-mentioned findings is considered
to indicate AAC. Generally patients present with similar
clinical manifestations: fever, nausea, vomiting, and pain in
the right upper quadrant. There are several reported cases
of acute hepatotropic virus infection (Epstein-Barr Virus,
hepatitis A, B, and C virus) and cholestatic hepatitis [13–17].
In our patient the cholestatic hepatitis was probably due to
HHV-6 infection. Quantification of HHV-6 DNA in blood
was positive and confirmed the acute infection. Also two
months later serologic test confirmed the HHV-6 infection.
The treatment of uncomplicated ACC is conservative and
symptomatic, which was done in our patient. It consists of
the application, according to needs, of analgesics, antiemetics,
antibiotics, fluid therapy, and parental nutrition. Abdominal
Computerized Tomography Scan (CT Scan) is reserved for
cases of suspected complications.
AAC is difficult to diagnose, but an early correct assess-
ment is essential to successful treatment. Clinicians should be
aware of the possible involvement of the gallbladder during
HHV-6 infection to avoid unnecessary invasive procedures
or overuse of antibiotics.
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